Podcasts about barouch

Show Notes: Lili Barouch, a cardiologist, went to medical school at Johns Hopkins.  After moving to Baltimore, she became a cardiologist specializing in heart failure and transplant. She joined the faculty in 2003 and worked on basic science research, research lab, and inpatient and outpatient care for heart failure and transplant patients. Lili stayed in this role for about 10 years before transitioning to outpatient cardiology. She moved to Howard County, Maryland, where her children have grown up. Founding the Sports Cardiology Program Lili started becoming more athletic around 20 years ago. This led to her interest in sports cardiology, a field geared towards athletes. She founded the sports cardiology program at Johns Hopkins and a training program for future sports cardiologists. She talks about building a new program from scratch, how the field of sports cardiology has grown significantly. Sports Cardiology Screening Sports cardiology involves screening athletes, including younger athletes, high-level athletes, and masters athletes. Screening includes evaluating athletes for risk factors, symptomatic athletes, those with known cardiac diseases, and those with significant changes in the heart due to high-level exertion. Lili talks about findings through screenings in sports cardiology including congenital heart defects, a family history of cardiac death at a young age, or abnormal ECGs. She mentions that there is no single standard throughout the country for what type of screening is required for college athletics. The general Sports Med and team physician screen everyone to a certain extent. Sports cardiologists typically are involved in second-level screening, for example, high blood pressure is an area that needs to be addressed, especially in younger athletes. By understanding the specifics of each type of screening and addressing any underlying conditions, athletes can better prepare for their future athletic careers. Stress Tests and ECG Abnormalities The conversation turns to the importance of stress tests and ECG abnormalities in sports. Athletes often tend to be symptom minimizers, ignoring minor symptoms that don't seem to affect anything at the time. However, many athletes who develop cardiac arrests report having some symptoms before they report them later. Lili talks about finding the balance between not wanting to alarm patients and not wanting them to ignore symptoms. Guidelines in Sports Cardiology Sports Cardiology is its own field. New guidelines have come out this year about shared decision making, which helps athletes decide whether to continue playing or not. The previous guidelines were more paternalistic, with doctors telling athletes whether they can play or are not allowed to play. This led to many athletes hiding symptoms or being disqualified. Newer guidelines have looked at more recent research studies to determine if restricting individuals actually helps them. Many places found that it's okay for athletes to participate in ways that were not possible 10 or 15 years ago, but it also affects their psychological state severely if they get disqualified from their sport. Changes to the Heart Lili discusses the changes to the heart of elite athletes, including professional athletes, major sports leagues, and Olympic athletes. She explains that the higher level of an athlete, the more likely they are to have more people involved in their care. Studies on elite athletes, such as Tour de France cyclists and Olympic athletes, have shown that those who do high levels of endurance exercise, such as cycling, long-distance running, swimming, and cross-country skiing, tend to have an increase in the size of their heart chambers. The Health Benefits of Exercise The American Heart Association guidelines recommend a minimum of two 30 minute strength training workouts and at least three 30 to 45 minute aerobic exercise workouts of moderate intensity per week. The minimum recommended amount of exercise is two and a half hours per week, spread out throughout the week. For endurance athletes, this may be more than two hours a day. Lili talks about the benefits of exercise, highlighting that there are marginal additional gains up to three to four times the minimum recommended amount. The most significant gain is when one goes from zero hours per week to two or three hours per week of total exercise, up to about eight hours per week. This leads to greater fitness, benefits in blood pressure, cholesterol, reducing the risk of diabetes, and longevity. However, beyond eight or 10 hours per week, there are no additional health benefits. Joining the Race Lili started running in 2006, initially as a fitness exercise but eventually becoming an athlete due to her autoimmune disease, rheumatoid arthritis. She joined the running club and was challenged by a friend to do a triathlon. She initially struggled with swimming, but eventually learned to swim and competed in several distances, including the full Ironman. Lili has run six marathons, mostly short and medium distance triathlons, and has achieved significant accomplishments such as qualifying for the Boston Marathon in 2018 and competing in the Boston Marathon in 2018. However, she also faced joint issues due to her rheumatoid arthritis, which led her to focus more on long distance triathlons. The Growth of the Sports Cardiology Program Lili founded a sports cardiology program based on her clinic, which primarily focuses on athlete patients. The program is also developing a National Registry of masters athletes to study the impact of high exercise levels on athletes' health. The program involves training fellows in cardiology who are interested in sports cardiology. A fellowship program was developed for one fellow, and the first formal graduates completed the program last year. Lili  talks about an annual meeting called "The Care of the Athletic Heart" in Washington, DC, where they organize formal talks, educational symposia, and case presentations to help others get into the field. She also talks about resources and funding for the program. Timestamps 02:19: Transition to Outpatient Cardiology and Personal Life  06:14: Evolution and Role in Sports Cardiology  07:05: Screening and Management of Athletes  15:25: Elite Athletes and Cardiac Health  27:15: Lily's Personal Athletic Journey 33:59: Founding the Sports Cardiology Program  37:26: Administrative and Research Aspects 40:56: Memorable Courses at Harvard  43:30: Resources and Future Plans Links: https://profiles.hopkinsmedicine.org/provider/lili-barouch/2705370 https://www.hopkinsmedicine.org/heart-vascular-institute/cardiology/sports-cardiology https://www.hopkinsmedicine.org/heart-vascular-institute/education/sports-cardiology-fellowship   Featured Non-profit: The featured non-profit of this episode of The 92 Report is recommended by Heather Taussig, class of ‘92, who reports:  “Hi, I'm Heather Taussig, class of 1992. The featured nonprofit of this episode of the 92 report is Fostering Healthy Futures. Fostering Healthy Futures is an evidence based mentoring program for children and teens in foster care. I am the program developer and principal investigator of Fostering Healthy Futures, which my team and I launched in 2002. You can learn more about our work at FosteringHealthyFuturesdotorg.“ To learn more about their work, visit: https://www.fosteringhealthyfutures.org/

Jonathan Barouch, CEO of Local Measure, joins us to discuss their journey of leading and innovating through a major business disruption.Topics Include:Intro to Local MeasureThe pre-Covid business model and customersImpact of CovidLosing 75% of their revenue within monthsTeams navigating the early months of CovidReinventing the businessTesting, iterating new business modelsLeveraging AWS APIs for Amazon Connect Cloud Contact Center solutionBalancing the former focus and contact centre pivotThe importance of a call centre in lean timesMigrating call centres of airlines and banks within 30 daysChange management and the Local Measure solutionLeveraging AI/ML for additional customer efficienciesShaving seconds off calls equate to huge savingsLeveraging AI/ML to turbocharge agentsAdditional industries for the Local Measure solutionTransforming data for tangible benefitProactive, predictive and outbound engagementsGuidance for other Software Executives going through disruptionWhat's next for Local MeasureInterview wrap up

Olivier Levy-Barouch, directeur général adjoint de La Banque Postale en charge de la direction finance et stratégie, et Marc Tempelman, cofondateur et président de Cashbee, étaient les invités de Frédéric Simottel dans Tech & Co, ce jeudi 23 juin. Ils sont revenus sur la stratégie d'innovation de la Banque Postale, sur BFM Business. Retrouvez l'émission du lundi au jeudi et réécoutez la en podcast.

We catch up with Dr. Barouch, the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center.

Jonathan Barouch is the founder and Chief Executive Officer of Local Measure. Local Measure is a customer experience platform for the hospitality, tourism, retail, and entertainment industries allowing businesses to receive real-time customer intelligence whenever customers are on-premise, helping them to identify, understand and retain customers.

Presentazione di Cristiana Santoni

In this episode, we meet Jonathan Barouch, serial entrepreneur and the founder and CEO of Local Measure. Jonathan was also the founder of fastflowers.com.au one of Australia's first e-commerce companies and is an ambassador for the Sydney Story Factory. www.chiefmaker.com/184 We talk all about: What he learned from his early days starting, growing and selling one of Australia's first e-commerce companies What most companies get wrong in measuring customer service How technology has helped transform the way we measure and engage with customer in real-time The importance of aligning technology and culture How employee experience is following the same path What the best leaders are doing right now to lead through the crisis

On Meet the Press, an exclusive joint interview with Dr. Peter Hotez, Director, Texas Children’s Hospital Center for Vaccine Development and Dr. Dan Barouch, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center. Gov. Mike DeWine (R-Ohio) talks to Chuck Todd about the importance of masks, during an exclusive interview. National Security Adviser Robert O’Brien says China is risking sanctions by pushing for more control over Hong Kong. Andrea Mitchell, O. Kay Henderson and Jeh Johnson join the Meet the Press roundtable.

(February 1, 2020) For many generations of South Bend residents, Studebaker Brothers - which later became the Studebaker Corp. - was the largest employer in town. It all began in 1852 when the two oldest of five Studebaker brothers - Henry and Clement - opened a blacksmith shop, pursuing a trade they had been taught by their father. By the 1880s, Studebaker was the largest maker of vehicles - wagons, carriages and sleds, at that point - in the world. Then came the heyday of auto production, with models like the Commander, the President, the moderately-priced Erskine and the luxurious Pierce-Arrow during the 1920s; the Land Cruiser in the 1930s; Champion Regal coupes in the 1950s; and the Avanti and the Daytona during the 1960s.  Although the final Studebaker car to be assembled in South Bend rolled off the production line in 1963, thousands of aficionados around the world continue to drive them. Among the most popular destinations for visitors to South Bend is the three-story Studebaker National Museum, where galleries include exhibits of U.S. presidential carriages. Among the crown jewels displayed at the Studebaker museum: the Barouch carriage that transported the Lincolns to Ford's Theatre on the the night of the president's assassination in 1865. For a motoring excursion through a broad landscape of Studebaker history, our two guests are: Andy Beckman of South Bend, the archivist for the Studebaker National Museum and past president of the Society of Automotive Historians. The museum, which has 55,000 square feet and galleries of vintage cars and wagons, also houses the archives of the Studebaker Corp. and other South Bend businesses dating to the 1850s. Bob Palma of Brownsburg, who writes Studebaker columns for auto collector publications, including Hemmings Classic Car magazine; he also serves as the technical editor for the Studebaker Drivers Club's magazine, Turning Wheels. The owner of a fleet of four Astra white 1964 Daytona models (the last model year of South Bend production), Bob is retired from a career that included teaching auto mechanics at Arsenal Tech High School and editing industrial arts textbooks. During the mid-1950s, his father co-owned a Studebaker dealership. Family connections have been part of the Studebaker heritage since the beginning. The fortunes of the wagon-making business are said to have been jump-started when John Mohler (J.M.) Studebaker, the third of the five brothers, returned from California to invest in his siblings' company. J.M. (1833-1917) had become wealthy by selling wheelbarrows to miners during the Gold Rush. At various times, all five Studebaker brothers were involved in the business, although Clement (1831-1901), J.M. and Peter (1836-1897) were most closely associated with it. Clement's mansion, built during the 1880s and christened Tippecanoe Place, is now home to a popular restaurant in South Bend. During World War II, Studebaker manufactured trucks and other vehicles used by the military. After the war, the company returned to making popular cars for middle-class Americans; our guest Bob Palma notes their 1947 models were touted with the slogan "first by far with a postwar car." Other history facts: Perhaps the most famous Studebaker models were the "bullet-nosed" cars of the early 1950s. Bullet-nosed Champions, Commanders and Land Cruisers were manufactured then. Although Studebaker was based in South Bend, the Hoosier city wasn't the only site of its plants. In fact, a factory in Hamilton, Ontario, Canada, continued to build cars for a few years after assembly operations in South Bend closed in 1963. During our show, guest Bob Palma explains how he and other enthusiasts obtain replacement parts for the cherished Studebakers that they continue to drive. Studebaker cars competed in the Indianapolis 500 during the early 1930s. For the 1962 race, the newly introduced Daytona convertible was the pace car.

Finally! Finally, thanks to Local measure's Jonathan Barouch, we're all going to discover how to create an incredible customer experience that will make it easier to do business with us, infinitely more enjoyable and crazily shareable. It's a highly experiential episode 486 of The (award-winning) Small Business Big Marketing Show thanks to American Express.   A little bit more about Local Measure's Jonathan Barouch … Marketing is full of jargon, right? And probably the most bandied around term of recent years has been customer experience, or CX as those in the know like to call it. But what is it? Why's it important? How can it help grow my business? And if it can, how do I get some of that action? All excellent questions, which are about to be answered by customer experience expert Jonathan Barouch, who is the founder of real-time customer intelligence company Local Measure .... and is also one of Australia's most respected tech entrepreneurs. Local Measure is next generation customer experience (mainly in the hospitality, travel & tourism sectors), providing highly-targeted, real-time customer intelligence, insight and demographic info to businesses about their customers. So if the idea of wowing those precious customers of yours appeals, then grab a pen and paper (I know, how old school!) and get ready to be wowed yourself. I started off by asking Jonathan to share the best customer experience he'd ever had.   “It's so much easier for a small business to deliver an incredible customer experience than it is for a big one.”    - Jonathan Barouch, Local Measure   Here's what caught my attention from my chat with Local Measure's Jonathan Barouch: I love the idea of giving deep consideration to the end-to-end journey of the customer as they travel through your business, the whole time asking yourself “How do I want my customer to feel?” I love that Jonathan acknowledges that B2B and B2C are just a distraction from the real way of doing business which is H2H (human-to-human) or P2P as I like to call it … people-to-people.  Be mindful of the fact that every customer now has a megaphone and more and more are willing to use it, thanks to social media, Google Reviews, and other review sites. So actively seek good reviews and testimonials, and be sure to respond to the good and bad ones.   “We need to start looking at our customers more holistically … from every angle …. And all the way along the purchase cycle.”    - Jonathan Barouch, Local Measure   Resources mentioned in episode 486 of The Small Business Big Marketing Show: Local Measure's official website Great customer experience case studies on the Local Measure website Last week's interview with rockstar Lachy Doley on how to make it big in the cut-throat music industry Interviews I've done about customer experience: Jay Baer on how to deal with customer complaints Joshua Nichols on his 21-step customer manifesto Zappo's Jenn Lim on delivering happiness   This week's Monster Prize Draw winner Peter Braid of Braid & Co   Please support the following businesses who make this show possible:   American Express Business Explorer Credit Card Let your business expenses reward you. Every year.   Switchnode Australia's Internet isn't great. That's why Switchnode exist. The solution is here and it's wireless.   If something in this episode of Australia's favourite marketing podcast peaked your interest, then let me know by leaving a comment below. May your marketing be the best marketing. [ For more interviews with successful business owners visit Small Business Big Marketing ] See omnystudio.com/listener for privacy information.

Why have scientists struggled to generate a protective HIV vaccine? Dan Barouch lays out the unique challenges and discusses the ongoing clinical trial with an adenovirus-based vaccine developed in his lab. Julie’s Biggest Takeaways HIV poses unique and unprecedented challenges for vaccine development including: Viral diversity: extremely wide range of viral diversity. No natural precedent: No human has cleared HIV based on their immune responses. Unknown correlates of protection: scientists are unsure what immune responses are important to induce. Barouch’s group uses a vaccine strategy comprised of computationally optimized mosaic HIV Env proteins, which represent pieces of the outermost glycoprotein, Env, that have been tied together in a way expected to generate protective immunity. Early data from animal and human trials suggests these mosaic antigens generate an immune response to a wider array of HIV types than previous vaccines. Clinical trials are ongoing to see if a strategy of mosaic antigen vaccination, followed by a boost with Env protein, is protective in people. Attenuated HIV hasn’t been used as a vaccine strategy because of fears it could revert to a disease-causing form; similar fears have prevented a whole-killed virus platform for vaccine development. A clinical trial testing safety in 3 locations around the world demonstrated that this vaccine strategy in people elicited immune responses shown to be protective in animals. An efficacy trial is ongoing in sub-Saharan Africa, with results expected in 2021. The trial is double blinded: neither the doctor nor the patient know who was administered the candidate vaccine or who was administered the placebo. HIV latent infection causes complications in vaccine development because HIV latency is seeded early, possibly in the first few days of infection. Once latency is established, the individual is infected for life. Any low level of HIV infection in vaccinated people could potentially seed this latent infection. Quickly-seeded latency means immune responses must react extremely quickly. Featured Quotes “The challenges in the development of a prophylactic HIV vaccine are among the toughest challenges in biomedical and scientific research.” “HIV poses unique challenges for vaccine development and truly unprecedented challenges that have never been posed before by vaccination. One such challenge is the viral diversity: HIV exists not as a single sequence, but as numerous different viral sequences — not only throughout the world, but also throughout regions, communities, and even within the same individual. So to create a vaccine against HIV, the immune responses have to be relevant for a vast diversity of viral sequences.” “At what efficacy level would an HIV vaccine be licenced by both the industry partners as well as the government regulators in a particular country, and at what level of efficacy would it actually have a major public health impact? It’s a moving target over time; it really depends on what the current state of the epidemic is at the time the vaccine is ready to be licensed.” “It’s critical to have high-quality research part of the clinical efficacy trials so that success or failure or something in between, that the HIV research field learns from it, and learns what worked well and what didn’t work well, and how to make better vaccines moving forward.” “I always encourage young scientists to pursue their dreams and to tackle hard problems. There’s a lot of easy problems to solve but some of the hardest problems are the most impactful in the end.” Links for This Episode MTM Listener Survey Barouch lab at the Center for Virology and Vaccine Research. MTM: Mark Connors. The Lancet: Evaluation of a Mosaic HIV-1 Vaccine in a Multicentre, Randomised, Double-Blide, Placebo-Controlled, Phase 1/2 a Clinical Trial (APPROACH) and in Rhesus Monkeys. The Lancet: A Step Forward for HIV Vaccines. Journal of Virology: Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys. PLoS One: First-in-Human Randomized, Controlled Trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. HOM Tidbit: I am the Berlin Patient: A Personal Reflection. HOM Tidbit: Doctor who cured Berlin Patient of HIV: ‘We knew we were doing something very special’.

Is it over commercialized? Yes. What's the point. Top 10 worst fathers day gifts. Hashtags and gary's favorite gift.

In the pre-production stages of the video podcasts. Tips & tricks riffs & sticks. I'll be discussing all things drums. From rudiments to drum set techniques. Thank you to Vic Firth & Zildjian for supplying me with the tools I need to pull this off. Subscribe now.

Dr. Dan Barouch is the Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and Harvard Medical School and a Program Leader at the Reagan Institute of Massachusetts General Hospital, MIT, and Harvard University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.H. Barouch. The Quest for an HIV-1 Vaccine - Moving Forward. N Engl J Med 2013;369:2073-6.

Jonathan Barouch talks about LocalMeasure

Here's a quick sample of some latin stuff

Just getting a drum check in the studio, nothing fancy. I've been working on my sound. It's getting better. Just waiting for some tracks to show up via FTP.

Orr Barouch, Midfielder, Chicago Fire, joins the show to discuss the Fire's pre-season and how the team is shaping up for the new MLS season.

This is my 1982 solo.